T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40348752.
- Also identified by DOI 10.1038/s41467-025-59370-5 and PMC identifier 12065855.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2022, a global mpox outbreak occurred, and remains a concern today. The T cell memory response to MPXV (monkeypox virus) infection has not been fully investigated. In this study, we evaluate this response in convalescent and MVA-BN (Modified Vaccinia Ankara - Bavarian Nordic) vaccinated individuals using VACV-infected cells. Strong CD8<sup>+</sup> and CD4<sup>+</sup> T cell responses are observed, and T cell responses are biased towards viral early expressed proteins. We identify seven immunodominant HLA-A*02:01 restricted MPXV-specific epitopes and focus our detailed phenotypic and scRNAseq analysis on the immunodominant HLA-A*02:01-G5R<sub>18-26</sub>-specific CD8<sup>+</sup> T cell response. While tetramer<sup>+</sup>CD8<sup>+</sup> T cells share similar differentiation and activation phenotypes, T cells from convalescent individuals show greater cytotoxicity, migratory potential to site of infection and TCR clonal expansion. Our data suggest that effective functional profiles of MPXV-specific memory T cells induced by Mpox infection may have an implication on the long-term protective responses to future infection.
Medical subject headings
- Immunologic Memory
- Memory T Cells
- Viral Vaccines
- Mpox, Monkeypox